BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4538646)

  • 21. [Case of Wiskott-Aldrich syndrome].
    Esposito L; Ferrara M; de Matteo R
    Pediatria (Napoli); 1975 Sep; 83(3):614-25. PubMed ID: 1223748
    [No Abstract]   [Full Text] [Related]  

  • 22. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
    Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two novel mutations in the WASP gene in Wiskott-Aldrich patients of Chile origin: W64R and A124E.
    Fillat C; Español T; Oset M; Cavieres M; dal Borgo P; Estivill X; Volpini V
    Hum Mutat; 2000 May; 15(5):487. PubMed ID: 10790228
    [No Abstract]   [Full Text] [Related]  

  • 24. Cutaneous T cell lymphoma and leukocytoclastic vasculitis in a long-term survivor of Wiskott-Aldrich syndrome.
    Watson RD; Gershwin ME; Smithwick E; Castles JJ; Ruebner B
    Ann Allergy; 1985 Nov; 55(5):654-7, 703-5. PubMed ID: 3877477
    [No Abstract]   [Full Text] [Related]  

  • 25. [The Wiskott-Aldrich syndrome].
    Belohradsky BH; Griscelli C; Fundenberg HH; Marget W
    Ergeb Inn Med Kinderheilkd; 1978; 41():85-184. PubMed ID: 361383
    [No Abstract]   [Full Text] [Related]  

  • 26. Wiskott-Aldrich syndrome: review of literature and report of case.
    Perino KE; James RB
    J Oral Surg; 1980 Apr; 38(4):297-303. PubMed ID: 6928459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sclerosing cholangitis and intracranial lymphoma in a child with classical Wiskott-Aldrich syndrome.
    Vignesh P; Suri D; Rawat A; Lau YL; Bhatia A; Das A; Srinivasan A; Dhandapani S
    Pediatr Blood Cancer; 2017 Jan; 64(1):106-109. PubMed ID: 27566838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes.
    Lemahieu V; Gastier JM; Francke U
    Hum Mutat; 1999; 14(1):54-66. PubMed ID: 10447259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dental considerations in the treatment of Wiskott-Aldrich syndrome: report of case.
    Boraz RA
    ASDC J Dent Child; 1989; 56(3):225-7. PubMed ID: 2656796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.
    Stewart DM; Tian L; Nelson DL
    J Immunol; 1999 Apr; 162(8):5019-24. PubMed ID: 10202051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical tacrolimus is effective against eczema in Wiskott-Aldrich syndrome (WAS).
    Bienemann K; Gudowius S; Niehues T
    Acta Paediatr; 2007 Feb; 96(2):312-4. PubMed ID: 17429928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Survival of platelets and of fibrinogen in a case of the Wiskott-Aldrich syndrome].
    Musumeci S; D'Agata A; Di Gregorio L
    Pediatria (Napoli); 1973 Oct; 81(3):490-501. PubMed ID: 4767797
    [No Abstract]   [Full Text] [Related]  

  • 33. Wiskott-Aldrich syndrome in Argentina: 17 unique, including nine novel, mutations.
    El-Hakeh J; Rosenzweig S; Oleastro M; Basack N; Berozdnik L; Molina F; Rivas EM; Zelazko M; Danielian S
    Hum Mutat; 2002 Feb; 19(2):186-7. PubMed ID: 11793485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An autopsy case of Wiskott-Aldrich syndrome in a 21-year-old male with renal failure (author's transl)].
    Tanaka S; Kita K; Yasue H; Ito T; Omine M; Horiuchi T
    Rinsho Ketsueki; 1978 Dec; 19(12):1665-71. PubMed ID: 739620
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. A unique disorder of serum protein metabolism.
    Blaese RM; Strober W; Levy AL; Waldmann TA
    J Clin Invest; 1971 Nov; 50(11):2331-8. PubMed ID: 5096517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
    Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
    Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
    Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
    Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of Wiskott-Aldrich syndrome in patients from India.
    David S; Jayandharan GR; Abraham A; Jacob RR; Devi GS; Patkar N; Shaji RV; Nair SC; Viswabandya A; Ahmed R; George B; Mathews V; Chandy M; Srivastava A
    Eur J Haematol; 2012 Oct; 89(4):356-60. PubMed ID: 22679904
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of six novel WASP gene mutations in patients suffering from Wiskott-Aldrich syndrome.
    Brooimans RA; van den Berg AJ; Tamminga RY; Revesz T; Wulffraat NM; Zegers BJ
    Hum Mutat; 2000 Apr; 15(4):386-7. PubMed ID: 10737997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wiskott-Aldrich syndrome.
    Srivastava RN
    Arch Dis Child; 1967 Dec; 42(226):604-7. PubMed ID: 6073827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.